arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Personalis, Inc.

PSNL
$16.34 ▼ -0.02 (-0.09%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
36 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

Personalis, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield
Revenue Growth 30.0%
Op. Margin -150.2%
ROIC -14.3%
FCF / Share $-0.28
Trailing P/E
Price / Book 7.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

36-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$22.36M
↑ +30.0%
Net Income Profit after all expenses
$-31.68M
↓ -58.0%
Operating Margin Operating profit as % of sales
-150.2%
↑ +27.7% 1th
FCF / Share Free cash flow per share
$-0.28
↓ -13.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
23
Financial Health
7
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 36 quarters